Achieve Life Sciences (ACHV) Shares Issued (2010 - 2026)

Achieve Life Sciences' Shares Issued history runs 17 years deep, the most recent figure standing at $5.0 million for Q1 2026.

• Quarterly Shares Issued rose 119.55% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 million (up 119.55% YoY) and the FY2025 annual result came in at $2.7 million, up 27.61% from the prior year.
• Shares Issued was $5.0 million for Q1 2026 at Achieve Life Sciences, up from $2.7 million in the prior quarter.
• Across five years, Shares Issued topped out at $5.0 million in Q1 2026 and bottomed at $789940.0 in Q1 2022.
• A 5-year average of $1.8 million and a median of $1.9 million in 2024 frame the typical range for Shares Issued.
• Annual changes were most pronounced in 2025 — Shares Issued rose 9.63% — and 2026, when it jumped 119.55%.
• Achieve Life Sciences' Shares Issued stood at $822515.0 in 2022, then soared by 77.75% to $1.5 million in 2023, then surged by 46.34% to $2.1 million in 2024, then increased by 27.61% to $2.7 million in 2025, then surged by 82.06% to $5.0 million in 2026.
• Business Quant data shows ACHV's Shares Issued at $5.0 million in Q1 2026, $2.7 million in Q4 2025, and $2.1 million in Q3 2025.